Vybrané polyfenolické látky a jejich použití jako podpůrná terapie metabolického syndromu.
- Published in:
- Czech & Slovak Pharmacy / Česká a Slovenská Farmacie, 2022, v. 71, n. 4, p. 137
- By:
- Publication type:
- Article
Works by Vecera, Rostislav
Results: 18
1
2
Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 212, doi. 10.3390/biomedicines13010212
- By:
- Publication type:
- Article
3
The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 45, doi. 10.3390/pharmaceutics14010045
- By:
- Publication type:
- Article
4
Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome.
- Published in:
- Xenobiotica, 2019, v. 49, n. 11, p. 1296, doi. 10.1080/00498254.2018.1558310
- By:
- Publication type:
- Article
5
The Combination of Atorvastatin With Silymarin Enhances Hypolipidemic, Antioxidant and Anti-Inflammatory Effects in a Rat Model of Metabolic Syndrome.
- Published in:
- Physiological Research, 2021, v. 70, n. 1, p. 33, doi. 10.33549/physiolres.934587
- By:
- Publication type:
- Article
6
Critical evaluation of colon submucosal microdialysis in awake, mobile rats.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191041
- By:
- Publication type:
- Article
7
Influence of probiotic E. coli strain Nissle 1917 on the pharmacokinetics of amiodarone in the rat.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2012, v. 156, n. Supp 3, p. S123
- By:
- Publication type:
- Article
8
LETTER TO THE EDITOR.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2012, v. 156, n. 4, p. 317
- By:
- Publication type:
- Article
9
Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat.
- Published in:
- Biopharmaceutics & Drug Disposition, 2011, v. 32, n. 8, p. 482, doi. 10.1002/bdd.774
- By:
- Publication type:
- Article
10
23. česká konference klinické farmakologie Olomouc, 7.–9. září 2023.
- Published in:
- Klinická Farmakologie a Farmacie, 2023, v. 37, n. 3, p. 142
- By:
- Publication type:
- Article
11
Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220377
- By:
- Publication type:
- Article
12
Výplach žaludku při perorální intoxikaci -- sporné pohledy na problematiku.
- Published in:
- Journal of Czech Physicians / Časopis Lékařů Českých, 2015, v. 154, n. 4, p. 174
- By:
- Publication type:
- Article
13
Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of <i>E. coli</i> Nissle 1917 on Amidarone Absorption in Rats.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087150
- By:
- Publication type:
- Article
14
The Influence of Maca (Lepidium meyenii) on Antioxidant Status, Lipid and Glucose Metabolism in Rat.
- Published in:
- Plant Foods for Human Nutrition, 2007, v. 62, n. 2, p. 59, doi. 10.1007/s11130-007-0042-z
- By:
- Publication type:
- Article
15
Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00056
- By:
- Publication type:
- Article
16
Improvement bioavailability of silymarin ameliorates severe dyslipidemia associated with metabolic syndrome.
- Published in:
- Xenobiotica, 2015, v. 45, n. 9, p. 751, doi. 10.3109/00498254.2015.1010633
- By:
- Publication type:
- Article
17
Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.
- Published in:
- Xenobiotica, 2012, v. 42, n. 8, p. 731, doi. 10.3109/00498254.2012.661099
- By:
- Publication type:
- Article
18
Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum.
- Published in:
- Phytotherapy Research, 2003, v. 17, n. 5, p. 524
- By:
- Publication type:
- Article